Medtronic plc

MDT ·Healthcare, Medical Devices
Financial Statements Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2018 FY2017 FY2016 FY2015 FY2014 FY2013
Operating Activities
Net Income $3.10B $4.03B $3.54B $2.68B $3.07B $3.47B
Depreciation & Amortization $2.64B $2.92B $2.82B $1.31B $850.0M $819.0M
Depreciation $821.0M $937.0M $889.0M $573.0M $501.0M $488.0M
Amortization $1.82B $1.98B $1.93B $733.0M $349.0M $331.0M
Stock-Based Compensation $344.0M $348.0M $375.0M $439.0M $145.0M $152.0M
Net Cash from Operating Activities $4.68B $6.88B $5.22B $4.90B $4.96B $4.94B
Investing Activities
Capital Expenditures $1.07B $1.25B $1.05B $571.0M $396.0M $457.0M
Business Acquisitions $137.0M $1.32B $1.21B $14.88B $385.0M $820.0M
Net Cash from Investing Activities $5.86B $-1.57B $2.25B $-17.06B $-3.59B
Financing Activities
Dividends Paid $2.49B $2.38B $2.14B $1.34B $1.12B $1.06B
Stock Repurchases $2.17B $3.54B $2.83B $1.92B $2.55B $1.25B
Net Cash from Financing Activities $-11.95B $-3.28B $-9.54B $15.95B $-918.0M
Net Change in Cash $-1.30B $2.09B $-1.97B $3.44B $484.0M $-253.0M
Free Cash Flow $3.62B $5.63B $4.17B $4.33B $4.56B $4.49B
← Newer Page 2 of 2 Older →